Biogen Stock Is Mutating Into a Value Play

Biogen TodayBIIBBiogen$136.54 -0.04 (-0.03%) 52-Week Range$128.51▼$238.00P/E Ratio12.20Price Target$211.85Add to WatchlistBiogen Inc. NASDAQ: BIIB has steadily declined since peaking at $468.55 in 2021, as shares are trading down 70.64% from those highs to 12-year lows at $137.33. The medical sector biotechnology company is trading at historically low valuations at a 12.41 price-earnings (P/E) ratio, which is less than half of the industry average P/E of 29.52. Its price-book (P/B) ratio is 1.2, significan ...